Until there is a cure, early detection is critical to breast cancer survival. If the cancer is located only in the breast at the time of diagnosis, the average 5 year survival is 99%*. If the cancer has spread to a distant part of the body, the 5-year survival rate is 26%*. The key is to find the disease early so treatment can start earlier.
Image quality is critical to detecting tumors, especially small ones at the early stage. Many factors can affect the ability to capture diagnostic information through varying breast tissue densities while striving to keep radiation dose as low as possible.
ASPIRE™ Cristalle, a digital mammography system, is designed with every aspect of a patient’s experience in mind, making it possible to increase patient comfort and improve the patient experience.
When it comes to mammography, patient comfort is not just physical. It can be an anxiety-inducing examination, especially if exams need to be repeated or the patient is concerned about radiation exposure.
An easy-to-use, reliable system is important to ensure uptime and cost savings. It also adds to a positive overall patient experience by providing an uninterrupted and efficient exam. It’s only natural that patients want personalized attention. The more clinicians can dedicate to the patient instead of the equipment, the greater patient satisfaction can be.
* Statistics adapted from the American Cancer Society's publication, cancer Facts & Figures 2016, and the National Cancer Institute Surveillance Epidemiology and End Results (SEER) database; http://www.cancer.net/cancer-types/breast-cancer/statistics